Filter posts

BIO Fall IPCC Meeting: Special Offer for First Time In-House Attendees!

Are you a patent practitioner at a biotech company? Is your in-house IP group small, …

Registration for BIO's Fall IP Counsels Committee Conference is NOW OPEN!

Ah, Autumn. A time for pumpkin spice lattes, cozy sweaters, soup, and updates in the …

Making the Case for Ag Innovation

Modern ag is multi-faceted, innovative, and above all, critical for feeding a growing population. At …

Through New Technology, Agriculture is Leading the Way on Innovation

Whether through biotechnology or even robots, agriculture is leading the way on innovation. In Salinas …

BIO Chimes In: TC Heartland LLC v. Kraft Food Brands Group LLC (Supreme Court)

This is part two of a three part series on BIO’s recently submitted amicus briefs in cases …

PTAB, IPRs and Uncertainty in the Patent System

The topic of inter partes reviews (IPRs) has dominated conversation in patent circles for the …

BIO Releases Points to Consider on Truthful and Non-Misleading Product Communication

Today, BIO releases Points to Consider on Truthful and Non-Misleading Product Communication. This document advances the dialogue …

Orphan Drug Tax Credit is Crucial to Rare Disease R&D

The term “rare disease” may be misleading: to be “rare” a disease must effect fewer …

IP Sessions at the 2015 BIO International Convention

This year’s BIO International Convention will be host to educational sessions on the latest issues …

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small …